WHO ICTRP trial

A Prospective Cohort Study on the Treatment of Elderly Patients with Heart…

ITMCTR2025000176 · International Traditional Medicine Clinical Trial Registry (ITMCTR) · Recruiting

Key facts

Trial ID ITMCTR2025000176
Public title A Prospective Cohort Study on the Treatment of Elderly Patients with Heart Failure with Preserved Ejection Fraction and Frailty Using Yiqi Fumai Injection
Scientific title A Prospective Cohort Study on the Treatment of Elderly Patients with Heart Failure with Preserved Ejection Fraction and Frailty Using Yiqi Fumai Injection
Primary sponsor The First Teaching Hospital of Tianjin University of Traditional Chinese Medicine
Registry International Traditional Medicine Clinical Trial Registry (ITMCTR)
Recruitment status Recruiting
Study type Observational study
Phase Others
Countries CHINA
Conditions Elderly Heart Failure with Preserved Ejection Fraction (HFpEF) and Frailty
Interventions "Exposed group":On the basis of the control group an additional treatment of Yiqi Fumai Injection (manufactured by Tianjin Tasly-Tjq Pharmaceutical Co. Ltd. National Medical Products Administration Approval Number: Z20060463 with a dosage…
Registration date Jan 25, 2025
Target size "Exposed group":64;"Non-exposed group":64
Registry page itmctr.ccebtcm.org.cn

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations